Last Updated on October 7, 2020 by Arslan Mohamed

NY Hep C Telemedicine Workgroup – Meeting Notes

Thursday September 16 (10 – 11 AM) via Webinar

In attendance at this meeting: See below notes 

Workgroup Chair: Andrew Talal, MD, University at Buffalo,

Workgroup goals: Short term: Identify, assess, document and disseminate current strategies and opportunities to provide hepatitis C treatment in substance use treatment facilities, via telemedicine. Long-term: Develop a NYS Telehealth network to provide a forum for ongoing learning and sharing of best practices to promote hepatitis B and C care and treatment through telehealth.

Meeting Notes

Implementing Hep C Treatment and Telehealth at REACH
Justine Waldman, MD –

  • Rapid implementation of telehealth in March 2020
  • Important to select a platform that does not require an app for ease of use to patients
  • HCV and HIV testing are offered at intake and all visits as appropriate but some decline, postpone or have fear of stigma
  • Challenges include assisting those affected by criminal justice system, payment models and stigma around buprenorphine
  • See presentation here.

Proposed changes to telehealth benefits for CMS,
Frank Winter – 

  • CMS expects waivers to remain for the duration of the public health emergency or until December 31, 2021
  • Waivers include expanded coverage of telehealth technologies
  • Submit comments on the Physician Fee Schedule Final Rule here.
  • See presentation here.



  1. Andrew Talal, MD, SUNY Research Foundation,
  2. Jeff Weiss, REACH,
  3. Frank Winter, CMS,
  4. Pat Lincourt , NYS OASAS,
  5. Colleen Flanigan, RN, NYS DOH,
  6. Nadine Kela-Murphy, MPH, NYC DOHMH,
  7. Nirah Johnson, LCSW, NYC DOHMH,
  8. Meg Chappell, MPH, Empire Liver Foundation,
  9. Darlene Meyer, SUNY,
  10. Marie Bresnahan, MPH, NYC DOHMH,
  11. Daanish Shaikh, START Treatment and Recovery Centers,
  12. Alvin Chu, MA, MPH, START Treatment and Recovery Centers,
  13. Rebecca LaMarca, START Treatment and Recovery Centers,
  14. Anthony McLeod, START Treatment and Recovery Centers,
  15. Kathleen Davis, University of Rochester Medical Center,
  16. Dan Shappee, AbbVie,
  17. Pruthvi Patel, Mount Sinai,
  18. Deborah Brown,
  19. Stephanie McHugh,
  20. Andrew Reynolds,
  21. Justine Waldman, REACH,
  22. Arslan Mohamed,
  23. Debra Farron, Gilead Science,
  24. Marc Badura, SUNY,
  25. Katy Cook, AHI,
  26. Joyce Gholson, START,

©2020 HepFree.NYC. All rights reserved. Site by Lookit®


Log in with your credentials

Forgot your details?